Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX

BACKGROUND: Metastatic pancreatic adenocarcinoma (MPA) represents a highly lethal condition. Despite the improvements seen with FOLFIRINOX, there is no randomized data to guide treatment selection beyond this regimen. We aimed to evaluate the outcomes of patients with MPA progressing on FOLFIRINOX w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastrointest Oncol
Hlavní autoři: de Jesus, Victor Hugo Fonseca, Camandaroba, Marcos Pedro Guedes, Donadio, Mauro Daniel Spina, Cabral, Audrey, Muniz, Thiago Pimentel, de Moura Leite, Luciana, Sant’Ana, Lucas Ferreira
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6219982/
https://ncbi.nlm.nih.gov/pubmed/30505579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.06.08
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky